{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T22:17:01Z","timestamp":1780611421113,"version":"3.54.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"crossref","award":["2016YFD0500400"],"award-info":[{"award-number":["2016YFD0500400"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Research of Guangdong Province and Ministry of Education","award":["2014B090901046"],"award-info":[{"award-number":["2014B090901046"]}]},{"DOI":"10.13039\/501100010042","name":"Special Fund for Agro-scientific Research in the Public Interest","doi-asserted-by":"crossref","award":["201103032"],"award-info":[{"award-number":["201103032"]}],"id":[{"id":"10.13039\/501100010042","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.vaccine.2016.12.069","type":"journal-article","created":{"date-parts":[[2017,1,12]],"date-time":"2017-01-12T15:54:07Z","timestamp":1484236447000},"page":"938-944","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Expression of interleukin-6 by a recombinant rabies virus enhances its immunogenicity as a potential vaccine"],"prefix":"10.1016","volume":"35","author":[{"given":"Jun","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyu","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingzhu","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongwen","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl","key":"10.1016\/j.vaccine.2016.12.069_b0005","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/S0264-410X(96)00312-X","article-title":"Rabies and rabies research: past, present and future","volume":"15","author":"Fu","year":"1997","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2016.12.069_b0010","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s11262-016-1313-2","article-title":"A recombinant rabies virus carrying GFP between N and P affects viral transcription in vitro","volume":"52","author":"Luo","year":"2016","journal-title":"Virus Genes"},{"issue":"18","key":"10.1016\/j.vaccine.2016.12.069_b0015","doi-asserted-by":"crossref","first-page":"9642","DOI":"10.1128\/JVI.00326-10","article-title":"Expression of MIP-1alpha (CCL3) by a recombinant rabies virus enhances its immunogenicity by inducing innate immunity and recruiting dendritic cells and B cells","volume":"84","author":"Zhao","year":"2010","journal-title":"J Virol"},{"issue":"20","key":"10.1016\/j.vaccine.2016.12.069_b0020","doi-asserted-by":"crossref","first-page":"10889","DOI":"10.1128\/JVI.77.20.10889-10899.2003","article-title":"Functional human immunodeficiency virus type 1 (HIV-1) Gag-Pol or HIV-1 Gag-Pol and env expressed from a single rhabdovirus-based vaccine vector genome","volume":"77","author":"McGettigan","year":"2003","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2016.12.069_b0025","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.virusres.2007.07.018","article-title":"Glycoprotein gene relocation in rabies virus","volume":"131","author":"Wu","year":"2008","journal-title":"Virus Res"},{"issue":"14","key":"10.1016\/j.vaccine.2016.12.069_b0030","doi-asserted-by":"crossref","first-page":"7310","DOI":"10.1073\/pnas.93.14.7310","article-title":"Highly stable expression of a foreign gene from rabies virus vectors","volume":"93","author":"Mebatsion","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.vaccine.2016.12.069_b0035","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3109\/13550289809113489","article-title":"Infection characteristics of rabies virus variants with deletion or insertion in the pseudogene sequence","volume":"4","author":"Ceccaldi","year":"1998","journal-title":"J Neurovirol"},{"issue":"18","key":"10.1016\/j.vaccine.2016.12.069_b0040","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1002\/j.1460-2075.1994.tb06739.x","article-title":"Infectious rabies viruses from cloned cDNA","volume":"13","author":"Schnell","year":"1994","journal-title":"Embo J"},{"issue":"1","key":"10.1016\/j.vaccine.2016.12.069_b0045","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1128\/JVI.01572-14","article-title":"Expression of interferon gamma by a recombinant rabies virus strongly attenuates the pathogenicity of the virus via induction of type I interferon","volume":"89","author":"Barkhouse","year":"2015","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2016.12.069_b0050","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1128\/JVI.01552-10","article-title":"Rabies virus expressing dendritic cell-activating molecules enhances the innate and adaptive immune response to vaccination","volume":"85","author":"Wen","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.12.069_b0055","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.virol.2014.09.010","article-title":"Recombinant rabies virus expressing IFNalpha1 enhanced immune responses resulting in its attenuation and stronger immunogenicity","volume":"468\u2013470","author":"Wang","year":"2014","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.vaccine.2016.12.069_b0060","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1084\/jem.167.2.332","article-title":"The essential role of B cell stimulatory factor 2 (BSF-2\/IL-6) for the terminal differentiation of B cells","volume":"167","author":"Muraguchi","year":"1988","journal-title":"J Exp Med"},{"issue":"5158","key":"10.1016\/j.vaccine.2016.12.069_b0065","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1126\/science.8160012","article-title":"The role of interleukin-6 in mucosal IgA antibody responses in vivo","volume":"264","author":"Ramsay","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2016.12.069_b0070","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1146\/annurev.iy.08.040190.001345","article-title":"Interleukin-6: an overview","volume":"8","author":"Van Snick","year":"1990","journal-title":"Annu Rev Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2016.12.069_b0075","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1128\/JVI.72.2.1704-1708.1998","article-title":"Coadministration of DNA encoding interleukin-6 and hemagglutinin confers protection from influenza virus challenge in mice","volume":"72","author":"Larsen","year":"1998","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2016.12.069_b0080","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0264-410X(98)00223-0","article-title":"IL-6 induces long-term protective immunity against a lethal challenge of influenza virus","volume":"17","author":"Lee","year":"1999","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2016.12.069_b0085","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/1348-0421.12244","article-title":"Enhancement of the immunogenicity of a porcine circovirus type 2 DNA vaccine by a recombinant plasmid coexpressing capsid protein and porcine interleukin-6 in mice","volume":"59","author":"Guo","year":"2015","journal-title":"Microbiol Immunol"},{"issue":"22","key":"10.1016\/j.vaccine.2016.12.069_b0090","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1016\/j.vaccine.2011.03.036","article-title":"Improvement of the immunity of pig to Hog cholera vaccine by recombinant plasmid with porcine interleukin-6 gene and CpG motifs","volume":"29","author":"Li","year":"2011","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2016.12.069_b0095","doi-asserted-by":"crossref","first-page":"e87105","DOI":"10.1371\/journal.pone.0087105","article-title":"A recombinant rabies virus encoding two copies of the glycoprotein gene confers protection in dogs against a virulent challenge","volume":"9","author":"Liu","year":"2014","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.vaccine.2016.12.069_b0100","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0022-1759(97)00212-3","article-title":"Development of a fluorescent antibody virus neutralisation test (FAVN test) for the quantitation of rabies-neutralising antibody","volume":"212","author":"Cliquet","year":"1998","journal-title":"J Immunol Methods"},{"issue":"37","key":"10.1016\/j.vaccine.2016.12.069_b0105","doi-asserted-by":"crossref","first-page":"4392","DOI":"10.1016\/j.vaccine.2016.07.020","article-title":"Two potential recombinant rabies vaccines expressing canine parvovirus virion protein 2 induce immunogenicity to canine parvovirus and rabies virus","volume":"34","author":"Luo","year":"2016","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2016.12.069_b0110","doi-asserted-by":"crossref","first-page":"7666","DOI":"10.4049\/jimmunol.176.12.7666","article-title":"Regional differences in blood-brain barrier permeability changes and inflammation in the apathogenic clearance of virus from the central nervous system","volume":"176","author":"Phares","year":"2006","journal-title":"J Immunol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2016.12.069_b0115","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.virusres.2009.03.014","article-title":"Role of chemokines in the enhancement of BBB permeability and inflammatory infiltration after rabies virus infection","volume":"144","author":"Kuang","year":"2009","journal-title":"Virus Res"},{"issue":"3","key":"10.1016\/j.vaccine.2016.12.069_b0120","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/j.1471-4159.2009.06366.x","article-title":"Context-dependent IL-6 potentiation of interferon- gamma-induced IL-12 secretion and CD40 expression in murine microglia","volume":"111","author":"Lin","year":"2009","journal-title":"J Neurochem"},{"issue":"36","key":"10.1016\/j.vaccine.2016.12.069_b0125","doi-asserted-by":"crossref","first-page":"4644","DOI":"10.1016\/j.vaccine.2014.06.058","article-title":"A recombinant rabies vaccine expressing the trimeric form of the glycoprotein confers enhanced immunogenicity and protection in outbred mice","volume":"32","author":"Koraka","year":"2014","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2016.12.069_b0130","doi-asserted-by":"crossref","first-page":"e1002971","DOI":"10.1371\/journal.ppat.1002971","article-title":"Immune clearance of attenuated rabies virus results in neuronal survival with altered gene expression","volume":"8","author":"Gomme","year":"2012","journal-title":"PLoS Pathog"},{"issue":"5","key":"10.1016\/j.vaccine.2016.12.069_b0135","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0301-0082(97)00021-X","article-title":"Interleukin-6 (IL-6)\u2013a molecule with both beneficial and destructive potentials","volume":"52","author":"Gadient","year":"1997","journal-title":"Prog Neurobiol"},{"issue":"Pt 8","key":"10.1016\/j.vaccine.2016.12.069_b0140","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1093\/brain\/awg171","article-title":"Lack of IL-6 augments inflammatory response but decreases vascular permeability in bacterial meningitis","volume":"126","author":"Paul","year":"2003","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.vaccine.2016.12.069_b0145","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.virusres.2006.01.014","article-title":"A highly attenuated rabies virus HEP-Flury strain reverts to virulent by single amino acid substitution to arginine at position 333 in glycoprotein","volume":"119","author":"Takayama-Ito","year":"2006","journal-title":"Virus Res"},{"issue":"8","key":"10.1016\/j.vaccine.2016.12.069_b0150","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1348-0421.2011.00354.x","article-title":"A unique transcription mode of rabies virus high egg passage-Flury strain detected in infected baby hamster kidney-21 cells","volume":"55","author":"Morimoto","year":"2011","journal-title":"Microbiol Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2016.12.069_b0155","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/intimm\/8.3.405","article-title":"CD40 expression and function in murine B cell ontogeny","volume":"8","author":"Castigli","year":"1996","journal-title":"Int Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2016.12.069_b0160","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.immuni.2011.07.010","article-title":"CD8(+) T cells: foot soldiers of the immune system","volume":"35","author":"Zhang","year":"2011","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.vaccine.2016.12.069_b0165","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.it.2013.10.012","article-title":"Innate antiviral signalling in the central nervous system","volume":"35","author":"Carty","year":"2014","journal-title":"Trends Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2016.12.069_b0170","doi-asserted-by":"crossref","first-page":"4698","DOI":"10.1128\/JVI.03149-13","article-title":"Enhancement of blood-brain barrier permeability and reduction of tight junction protein expression are modulated by chemokines\/cytokines induced by rabies virus infection","volume":"88","author":"Chai","year":"2014","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2016.12.069_b0175","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1128\/JVI.01964-06","article-title":"Failure to open the blood-brain barrier and deliver immune effectors to central nervous system tissues leads to the lethal outcome of silver-haired bat rabies virus infection","volume":"81","author":"Roy","year":"2007","journal-title":"J Virol"},{"issue":"10","key":"10.1016\/j.vaccine.2016.12.069_b0180","doi-asserted-by":"crossref","first-page":"e535","DOI":"10.1371\/journal.pntd.0000535","article-title":"The production of antibody by invading B cells is required for the clearance of rabies virus from the central nervous system","volume":"3","author":"Hooper","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2016.12.069_b0185","doi-asserted-by":"crossref","first-page":"550","DOI":"10.4049\/jimmunol.172.1.550","article-title":"IFN-inducible protein 10\/CXC chemokine ligand 10-independent induction of experimental autoimmune encephalomyelitis","volume":"172","author":"Klein","year":"2004","journal-title":"J Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17300063?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17300063?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T23:00:49Z","timestamp":1601334049000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17300063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S0264410X17300063"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.12.069","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression of interleukin-6 by a recombinant rabies virus enhances its immunogenicity as a potential vaccine","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.12.069","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}